References
- Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13:252–262.
- Stevens DL, Bisno AL, Chambers AF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of america. Available from: http://cid.oxfordjournals.org/content/early/2014/06/14/cid.ciu296.full.pdf+html. Accessed June 1, 2016.
- Stevens DL, Bisno AL, Chambers H, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373–1406.
- Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY antimicrobial surveillance program, 1997–1999. Clin Infect Dis. 2001;32:S114–32.
- Di Nubile MJ, Lipsky BA. Complicated infections of the skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53(Suppl 2):ii37–50.
- Dryden MS. Complicated skin and soft tissue infection. Chemother. 2010;65:35–44.
- Hepburn MJ, Dooley DP, Skidmore PJ, et al. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164:1669–1674.
- Lodise TP, Fan W, Sulham KA. Hospital admission patterns in adult patients with skin and soft tissue infections: identification of potentially avoidable hospital admissions through a retrospective database analysis. Hosp Pract. 2015;43(3):137–143.
- Jenkins TC, Sabel AL, Sarcone EE, et al. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis. 2010;51:895–903.
- Moet GJ, Jones RN, Biedenbach DJ, et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2007;57:7–13.
- Summamen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft tissue infections: a comparison of infections and intravenous drug users and individuals with no history of drug use. Clin Infect Dis. 1995;20:S279–82.
- Moran GJ, Amil RN, Abrahamian FM, et al. Methicillin-Resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11:928–930.
- Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674.
- Corey GR, Wilcox MH, Talbot GH, et al. CANVAS 1: the first Phase III, randomized, double-blind study evaluated ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65(4):41–51.
- Fitch MT, Manthey DE, McGinnis HD, et al. Videos in clinical medicine. Abscess incision and drainage. N Engl J Med. 2007 Nov 8;357(19):e20.
- Daum RS, Miller L, Immergluck L, et al. Clindamycin versus trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin and soft tissue abscesses. Open Forum Infect Dis Fall. 2016;3(Suppl 1). doi:10.1093/ofid/ofw194.111.
- Talan DA, Mower WR, Krishnadasan A, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–832.
- Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007;44(6):777–784.
- Peterson D, Mcleod S, Woofrey K, et al. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med. 2014;21:526–531.
- Murray H, Stiell I, Wells G. Treatment failure in emergency department patients with cellulitis. Can J Emergency Med. 2005;7:228–234.
- Jorup-Rönström C, Britton S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection. 1987;15:105–106.
- McNamara DR, Tleyjeh IM, Berbari EF, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167:709–715.
- Lewis SD, Peter GS, Gómez-Marín O, et al. Risk factors for recurrent lower extremity cellulitis in a U.S. Veterans Medical Center population. Am J Med Sci. 2006;332:304–307.